eKare Revenue and Competitors
Estimated Revenue & Valuation
- eKare's estimated annual revenue is currently $4.1M per year.
- eKare's estimated revenue per employee is $136,000
Employee Data
- eKare has 30 Employees.
- eKare grew their employee count by 30% last year.
eKare's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | VP Clinical Operations | Reveal Email/Phone |
3 | SVP, DATA SCIENCE | Reveal Email/Phone |
4 | DIRECTOR, OPERATIONS | Reveal Email/Phone |
eKare Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $51.9M | 314 | -2% | $12.4M | N/A |
#2 | $27.9M | 149 | N/A | N/A | N/A |
#3 | $4.1M | 30 | 30% | N/A | N/A |
#4 | $14.3M | 84 | 5% | N/A | N/A |
What Is eKare?
e-Kare Inc. is dedicated to the design and development of wound assessment solutions using the latest computer-vision and mobile technology. Founded by surgeons and leading experts in imaging sciences, e-Kare is a spin-off enterprise from the Children's National Health System, a premier pediatric health provider in Washington, DC. e-Kare's innovative technology is creating new possibilities in how we deliver wound care across the healthcare continuum, from inpatient hospital and skilled nursing facilities to ambulatory clinics and telemedicine.
keywords:N/AN/A
Total Funding
30
Number of Employees
$4.1M
Revenue (est)
30%
Employee Growth %
N/A
Valuation
N/A
Accelerator
eKare News
... and key Digital Wound Measurement Devices companies involved, such as Tissue Analytics, ARANZ Medical Limited, eKare, Inc, WoundMatrix,...
eKare Incorporated. Kent Imaging Incorporated. Net Health (Tissue Analytics, Incorporated). Perceptive Solutions, Incorporated.
... an illustrator from Japan; Agata Loth-Ignaciuk of Wydawnictwo Druganoga; Ekare's Irene Savino; and Italian illustrator Valerio Vidali.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $4.9M | 30 | 7% | N/A |
#2 | $4.8M | 30 | 7% | N/A |
#3 | $3.4M | 30 | 3% | N/A |
#4 | $6.1M | 30 | -3% | N/A |
#5 | $5.2M | 31 | 3% | N/A |